Genomic‐derived radiation dosage improves prediction of outcomes.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 5, doi. 10.3322/caac.21711
- Publication type:
- Article
Works matching IS 00079235 AND DT 2022 AND VI 72 AND IP 1
Results: 7
1
2
The social media cancer misinformation conundrum.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 3, doi. 10.3322/caac.21710
- Publication type:
- Article
3
Cancer statistics, 2022.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 7, doi. 10.3322/caac.21708
- By:
- Publication type:
- Article
4
Critical care management of chimeric antigen receptor T‐cell therapy recipients.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 78, doi. 10.3322/caac.21702
- By:
- Publication type:
- Article
5
Issue Information.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 1, doi. 10.3322/caac.21678
- Publication type:
- Article
6
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 34, doi. 10.3322/caac.21707
- By:
- Publication type:
- Article
7
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 1, p. 57, doi. 10.3322/caac.21704
- By:
- Publication type:
- Article